Menu
GeneBe

X-67545306-T-TTGC

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM4_SupportingPP5BS2

The NM_000044.6(AR):c.170_172dup(p.Leu57dup) variant causes a inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000245 in 1,143,668 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 9 hemizygotes in GnomAD. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00012 ( 0 hom., 5 hem., cov: 19)
Exomes 𝑓: 0.000017 ( 0 hom. 4 hem. )

Consequence

AR
NM_000044.6 inframe_insertion

Scores

Not classified

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:2U:1

Conservation

PhyloP100: 2.29
Variant links:
Genes affected
AR (HGNC:644): (androgen receptor) The androgen receptor gene is more than 90 kb long and codes for a protein that has 3 major functional domains: the N-terminal domain, DNA-binding domain, and androgen-binding domain. The protein functions as a steroid-hormone activated transcription factor. Upon binding the hormone ligand, the receptor dissociates from accessory proteins, translocates into the nucleus, dimerizes, and then stimulates transcription of androgen responsive genes. This gene contains 2 polymorphic trinucleotide repeat segments that encode polyglutamine and polyglycine tracts in the N-terminal transactivation domain of its protein. Expansion of the polyglutamine tract from the normal 9-34 repeats to the pathogenic 38-62 repeats causes spinal bulbar muscular atrophy (SBMA, also known as Kennedy's disease). Mutations in this gene are also associated with complete androgen insensitivity (CAIS). Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jan 2017]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM4
Nonframeshift variant in NON repetitive region in NM_000044.6. Strenght limited to Supporting due to length of the change: 1aa.
PP5
Variant X-67545306-T-TTGC is Pathogenic according to our data. Variant chrX-67545306-T-TTGC is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 958035.We mark this variant Likely_pathogenic, oryginal submissions are: {Uncertain_significance=1, Pathogenic=2}.
BS2
High Hemizygotes in GnomAd at 5 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
ARNM_000044.6 linkuse as main transcriptc.170_172dup p.Leu57dup inframe_insertion 1/8 ENST00000374690.9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
ARENST00000374690.9 linkuse as main transcriptc.170_172dup p.Leu57dup inframe_insertion 1/81 NM_000044.6 P1P10275-1

Frequencies

GnomAD3 genomes
AF:
0.000121
AC:
10
AN:
82407
Hom.:
0
Cov.:
19
AF XY:
0.000292
AC XY:
5
AN XY:
17137
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00539
Gnomad AMR
AF:
0.000290
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000121
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000189
AC:
3
AN:
158966
Hom.:
0
AF XY:
0.0000347
AC XY:
2
AN XY:
57580
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000417
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000170
AC:
18
AN:
1061261
Hom.:
0
Cov.:
30
AF XY:
0.0000116
AC XY:
4
AN XY:
343641
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.000133
Gnomad4 NFE exome
AF:
0.0000134
Gnomad4 OTH exome
AF:
0.0000228
GnomAD4 genome
AF:
0.000121
AC:
10
AN:
82407
Hom.:
0
Cov.:
19
AF XY:
0.000292
AC XY:
5
AN XY:
17137
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.000290
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000121
Gnomad4 OTH
AF:
0.00

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:2Uncertain:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Androgen resistance syndrome;C1839259:Kennedy disease Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingInvitaeJan 11, 2024This variant, c.170_172dup, results in the insertion of 1 amino acid(s) of the AR protein (p.Leu57dup), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs752055010, gnomAD 0.007%), including at least one homozygous and/or hemizygous individual. This variant has been observed in individual(s) with AR-related conditions (PMID: 25500996, 28261839; Invitae). In at least one individual the variant was observed to be de novo. This variant is also known as p.Leu57dup and p.57_58insLeu. ClinVar contains an entry for this variant (Variation ID: 958035). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. For these reasons, this variant has been classified as Pathogenic. -
Malignant tumor of prostate Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingMendelicsMay 04, 2022- -
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsOct 11, 2023The c.170_172dupTGC (p.L57dup) alteration, located in coding exon 1 of the AR gene. The alteration consists of an in-frame duplication of 3 nucleotides from position 170 to 172. This results in the duplication of a leucine residue at codon 57._x000D_ _x000D_ for AR-related androgen insensitivity syndrome; however, it is unlikely to be causative of AR-related spinal and bulbar muscular atrophy. Based on data from gnomAD, the c.170_172dupTGC allele has an overall frequency of 0.003% (6/174505) total alleles studied, with 2 hemizygotes observed. The highest observed frequency was 0.007% (1/14938) of African alleles. This variant has been reported in multiple individuals with features consistent with AR-related androgen insensitivity syndrome (Ferlin, 2006; Su, 2017; Liu, 2020), including a de novo occurrence (He, 2021). A functional study has demonstrated reduced cellular expression and transactivation activity in a luciferase assay (70% of wildtype) for p.L57dup (Tadokoro-Cuccaro, 2014). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs752055010; hg19: chrX-66765148; API